Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1978 Feb;40(2):170–176. doi: 10.1136/hrt.40.2.170

Plasma lipids in a London population and their relation to other risk factors for coronary heart disease.

J H Fuller, S Pinney, R J Jarrett, K Kilbourn, H Keen
PMCID: PMC482793  PMID: 205230

Full text

PDF
170

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albers J. J., Wahl P. W., Cabana V. G., Hazzard W. R., Hoover J. J. Quantitation of apolipoprotein A-I of human plasma high density lipoprotein. Metabolism. 1976 Jun;25(6):633–644. doi: 10.1016/0026-0495(76)90060-3. [DOI] [PubMed] [Google Scholar]
  2. BURSTEIN M., SAMAILLE J. Sur une nouvelle méthode de dosage du cholestérol lié aux alpha et aux beta-lipoprotéines du sérum. Clin Chim Acta. 1958 Jul;3(4):320–327. doi: 10.1016/0009-8981(58)90020-2. [DOI] [PubMed] [Google Scholar]
  3. Beaumont J. L., Carlson L. A., Cooper G. R., Fejfar Z., Fredrickson D. S., Strasser T. Classification of hyperlipidaemias and hyperlipoproteinaemias. Bull World Health Organ. 1970;43(6):891–915. [PMC free article] [PubMed] [Google Scholar]
  4. Bengtsson C., Tibblin E., Blohmé G., Gustafson A. Serum cholesterol and serum triglycerides in middle-aged women. The study of women in Göteborg 1968-69. Scand J Clin Lab Invest. 1974 Sep;34(1):61–66. doi: 10.3109/00365517409061822. [DOI] [PubMed] [Google Scholar]
  5. Bulpitt C. J., Hodes C., Everitt M. G. The relationship between blood pressure and biochemical risk factors in a general population. Br J Prev Soc Med. 1976 Sep;30(3):158–162. doi: 10.1136/jech.30.3.158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Carew T. E., Koschinsky T., Hayes S. B., Steinberg D. A mechanism by which high-density lipoproteins may slow the atherogenic process. Lancet. 1976 Jun 19;1(7973):1315–1317. doi: 10.1016/s0140-6736(76)92650-7. [DOI] [PubMed] [Google Scholar]
  7. Carlson L. A., Böttiger L. E. Ischaemic heart-disease in relation to fasting values of plasma triglycerides and cholesterol. Stockholm prospective study. Lancet. 1972 Apr 22;1(7756):865–868. doi: 10.1016/s0140-6736(72)90738-6. [DOI] [PubMed] [Google Scholar]
  8. Carlson L. A., Ericsson M. Quantitative and qualitative serum lipoprotein analysis. Part 1. Studies in healthy men and women. Atherosclerosis. 1975 May-Jun;21(3):417–433. doi: 10.1016/0021-9150(75)90054-4. [DOI] [PubMed] [Google Scholar]
  9. Carlson L. A., Lindstedt S. The Stockholm prospective study. 1. The initial values for plasma lipids. Acta Med Scand Suppl. 1968;493:1–135. [PubMed] [Google Scholar]
  10. Castelli W. P., Cooper G. R., Doyle J. T., Garcia-Palmieri M., Gordon T., Hames C., Hulley S. B., Kagan A., Kuchmak M., McGee D. Distribution of triglyceride and total, LDL and HDL cholesterol in several populations: a cooperative lipoprotein phenotyping study. J Chronic Dis. 1977 Mar;30(3):147–169. doi: 10.1016/0021-9681(77)90082-0. [DOI] [PubMed] [Google Scholar]
  11. Castelli W. P., Doyle J. T., Gordon T., Hames C. G., Hjortland M. C., Hulley S. B., Kagan A., Zukel W. J. HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. Circulation. 1977 May;55(5):767–772. doi: 10.1161/01.cir.55.5.767. [DOI] [PubMed] [Google Scholar]
  12. Cramp D. G., Robertson G. The fluorometric assay of triglyceride by a semiautomated method. Anal Biochem. 1968 Oct 24;25(1):246–251. doi: 10.1016/0003-2697(68)90097-3. [DOI] [PubMed] [Google Scholar]
  13. Fredrickson D. S. It's time to be practical. Circulation. 1975 Feb;51(2):209–211. doi: 10.1161/01.cir.51.2.209. [DOI] [PubMed] [Google Scholar]
  14. Fredrickson D. S., Levy R. I., Lees R. S. Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med. 1967 Jan 26;276(4):215–contd. doi: 10.1056/NEJM196701262760406. [DOI] [PubMed] [Google Scholar]
  15. Fuller J. H., Grainger S. L., jarrett R. J., Keen H. Possible seasonal variation of plasma lipids in a healthy population. Clin Chim Acta. 1974 May 17;52(3):305–310. doi: 10.1016/0009-8981(74)90115-6. [DOI] [PubMed] [Google Scholar]
  16. Gibson T. C., Whorton E. B. The prevalence of hyperlipidemia in a natural community. J Chronic Dis. 1973 Apr;26(4):227–236. doi: 10.1016/0021-9681(73)90103-3. [DOI] [PubMed] [Google Scholar]
  17. Glomset J. A. The plasma lecithins:cholesterol acyltransferase reaction. J Lipid Res. 1968 Mar;9(2):155–167. [PubMed] [Google Scholar]
  18. Gordon T., Castelli W. P., Hjortland M. C., Kannel W. B., Dawber T. R. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med. 1977 May;62(5):707–714. doi: 10.1016/0002-9343(77)90874-9. [DOI] [PubMed] [Google Scholar]
  19. Hazzard W. R., Goldstein J. L., Schrott M. G., Motulsky A. G., Bierman E. L. Hyperlipidemia in coronary heart disease. 3. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction. J Clin Invest. 1973 Jul;52(7):1569–1577. doi: 10.1172/JCI107333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kannel W. B., Castelli W. P., Gordon T., McNamara P. M. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med. 1971 Jan;74(1):1–12. doi: 10.7326/0003-4819-74-1-1. [DOI] [PubMed] [Google Scholar]
  21. Kannel W. B., LeBauer E. J., Dawber T. R., McNamara P. M. Relation of body weight to development of coronary heart disease. The Framingham study. Circulation. 1967 Apr;35(4):734–744. doi: 10.1161/01.cir.35.4.734. [DOI] [PubMed] [Google Scholar]
  22. Lewis B., Chait A., Wootton I. D., Oakley C. M., Krikler D. M., Sigurdsson G., February A., Maurer B., Birkhead J. Frequency of risk factors for ischaemic heart-disease in a healthy British population. With particular reference to serum-lipoprotein levels. Lancet. 1974 Feb 2;1(7849):141–146. doi: 10.1016/s0140-6736(74)92438-6. [DOI] [PubMed] [Google Scholar]
  23. Lorimer A. R., Cox F. C., Greaves D. A., Jubb J. S., Hawthorne V. M., Morgan H. G., Lawrie T. D. Prevalence of hyperlipoproteinaemia in apparently healthy men. Br Heart J. 1974 Feb;36(2):192–196. doi: 10.1136/hrt.36.2.192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Miller G. J., Miller N. E., Ashcroft M. T. Inverse relationship in Jamaica between plasma high-density lipoprotein cholesterol concentration and coronary-disease risk as predicted by multiple risk-factor status. Clin Sci Mol Med. 1976 Nov;51(5):475–482. doi: 10.1042/cs0510475. [DOI] [PubMed] [Google Scholar]
  25. Miller G. J., Miller N. E. Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet. 1975 Jan 4;1(7897):16–19. doi: 10.1016/s0140-6736(75)92376-4. [DOI] [PubMed] [Google Scholar]
  26. Noble R. P. Electrophoretic separation of plasma lipoproteins in agarose gel. J Lipid Res. 1968 Nov;9(6):693–700. [PubMed] [Google Scholar]
  27. Olsson A. G., Carlson L. A. Studies in asymptomatic primary hyperlipidaemia. I. Types of hyperlipoproteinaemias and serum lipoprotein concentrations, compositions and interrelations. Acta Med Scand Suppl. 1975;580:1–37. [PubMed] [Google Scholar]
  28. Onongbu I. C., Lewis B. Lipoprotein fractionation by a precipitation method. A simple quantitative procedure. Clin Chim Acta. 1976 Sep 20;71(3):397–402. doi: 10.1016/0009-8981(76)90090-5. [DOI] [PubMed] [Google Scholar]
  29. Reid D. D., Hamilton P. J., McCartney P., Rose G., Jarrett R. J., Keen H. Smoking and other risk factors for coronary heart-disease in British civil servants. Lancet. 1976 Nov 6;2(7993):979–984. doi: 10.1016/s0140-6736(76)90830-8. [DOI] [PubMed] [Google Scholar]
  30. Rhoads G. G., Gulbrandsen C. L., Kagan A. Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men. N Engl J Med. 1976 Feb 5;294(6):293–298. doi: 10.1056/NEJM197602052940601. [DOI] [PubMed] [Google Scholar]
  31. Rose G. Detection of high coronary risk. Postgrad Med J. 1976 Jul;52(609):452–455. doi: 10.1136/pgmj.52.609.452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Schilling F. J., Christakis G., Orbach A., Becker W. H. Serum cholesterol and triglyceride. An epidemiological and pathogenetic interpretation. Am J Clin Nutr. 1969 Feb;22(2):133–138. doi: 10.1093/ajcn/22.2.133. [DOI] [PubMed] [Google Scholar]
  33. Stein Y., Stein O. Cholesterol removal isolated cells and in tissue culture. Triangle. 1976;15(2-3):63–69. [PubMed] [Google Scholar]
  34. Thelle D. S., Føorde O. H., Try K., Lehmann E. H. The Tromsøo heart study. Methods and main results of the cross-sectional study. Acta Med Scand. 1976;200(1-2):107–118. [PubMed] [Google Scholar]
  35. Whitehead T. P., Browning D. M., Gregory A. A comparative survey of the results of analyses of blood serum in clinical chemistry laboratories in the United Kingdom. J Clin Pathol. 1973 Jun;26(6):435–445. doi: 10.1136/jcp.26.6.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Wilhelmsen L., Wedel H., Tibblin G. Multivariate analysis of risk factors for coronary heart disease. Circulation. 1973 Nov;48(5):950–958. doi: 10.1161/01.cir.48.5.950. [DOI] [PubMed] [Google Scholar]
  37. Wood P. D., Stern M. P., Silvers A., Reaven G. M., von der Groeben J. Prevalence of plasma lipoprotein abnormalities in a free-living population of the Central Valley, California. Circulation. 1972 Jan;45(1):114–126. doi: 10.1161/01.cir.45.1.114. [DOI] [PubMed] [Google Scholar]
  38. Wright I. S. Correct levels of serum cholesterol. Average vs normal vs optimal. JAMA. 1976 Jul 19;236(3):261–262. [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES